ADME Study of [14C]ICP-022 in Healthy Males

key Inclusion criteria: 1. Weight: Body mass index (BMI) is 19\~26 kg/m2 2. signing of informed consent 3. Volunteers are able to communicate well with the investigators and be able to complete the trial according to the process Key Exclusion Criteria: 1. physical examination, vital signs, routine laboratory tests (blood routine, blood biochemistry, blood coagulation routine, urine routine, stool routine + occult blood, serum amylase, thyroid function, etc.), 12-lead ECG, Chest X-ray (Anteroposterior), abdominal B-ultrasound (hepatobiliary, pancreas, spleen and kidney) and other abnormalities and clinical significance. 2. ophthalmologic examination shows abnormality and clinical significance 3. Positive test for hepatitis B (surface antigens HBs), or C (antibody HCs), positive test for HIV, positive test for Syphilis antibody. 4. Within 1 month before the screening, having not limited to known as hepatic enzyme inducers, inhibitors or substrates; (eg, inducer - barbiturate, carbamazepine, phenytoin, rifampicin, dexamethasone, rifabutin, rifapentine; inhibitors - SSRI antidepressants, cimetidine, diltiazem, macrolides, verapamil, imidazole antifungals) ; 5. Within 1 month before the screening, receiving the anticoagulant therapy such as warfarin or thrombin inhibitor and/or aspirin antiplatelet therapy NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.